Compounds > 3,4-dihydroxyphenylacetic acid
Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Cardiomyopathies

3,4-dihydroxyphenylacetic acid has been researched along with Cardiomyopathies in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moussouttas, M1
Lai, EW1
Dombrowski, K1
Huynh, TT1
Khoury, J1
Carmona, G1
DeCaro, M1
Pacak, K1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Cardiomyopathies

ArticleYear
CSF catecholamine profile in subarachnoid hemorrhage patients with neurogenic cardiomyopathy.
    Neurocritical care, 2011, Volume: 14, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Cardiomyopathies; Catecholamines; Dihydroxyphenylalanine; Dopa

2011